FDA's Draft Guidance Proposes Ways to Increase Patient Diversity in Clinical Trials

On June 6, the U.S. Food and Drug Administration (FDA) issued a draft guidance on improving the diversity of patient populations in clinical trials. Public comments are expected through August 6, 2019.